US Stock MarketDetailed Quotes

ENFN Enfusion

Watchlist
  • 9.230
  • +0.130+1.43%
Close Mar 27 16:00 ET
829.51MMarket Cap131.86P/E (TTM)
Pre-Market
  • 5D
  • 1D
  • 1W
  • 1M
  • 1Q
  • 1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

Comments

    Enfusion's decent ROE doesn't translate into growth due to a five-year net income decline. High payout ratio or poor capital allocation might be hampering growth. Despite high ROE and profit retention, earnings growth is below expectations, indicating possible external threats.

    ColumnsToday's Morning Movers and Top Ratings: GM, SMCI, UPS, SPOT and More

    Morning Movers
    Gapping up
    $General Motors(GM.US)$ stock soared 7.8% after the auto giant reported lower pretax profit for the fourth quarter but gave investors an upbeat outlook for 2024 and signaled more capital could be returned to shareholders.
    $Pfizer(PFE.US)$ stock rose 1.1% after the drugmaker reported a surprise quarterly profit, helped by COVID products demand being stronger than expectations and lower research costs.
    $Ford Motor(F.US)$ stock ros...
    Today's Morning Movers and Top Ratings: GM, SMCI, UPS, SPOT and More
    1
    Enfusion's ROCE shows a worrisome downward trend despite sales growth and reinvestment. Efficiency in generating ROCE may be on a decline as the company increasingly funds operations with its own money.
    Enfusion's current trading price suggests a potential to buy low. However, due to low volatility and other fiscal factors, ENFN's intrinsic value may take time to reach, possibly limiting future low-price buying chances. Its high growth potential at a cheap price makes it a compelling investment.

    ColumnsIPO Recap | Hot dog chain Portillo's soared 45% in Nasdaq debut

    On the last trading day, the S&P 500 index climbed 0.30%, while the NASDAQ Composite index rose 0.62%, and the Dow Jones Industrial Average dropped0.02%.
    On Thursday, there was no traditional IPO filed and six new stocks officially listed for trading. Restaurant chain Portillo's soared45.5% in its trading debut, valued at $2.08 billion.Ventyx Biosciencessurged31.38% in market debut, valued at $0.99 billion.
    Restaurant chain$Portillo’s Inc.(PTLO.US)$, founded in 1963 and known for its hot dogs and chocolate cake, is also going public.
    Since its founding in a small trailer which Dick Portillo called 「The Dog House,」 Portillo’s has grown to become a treasured brand with a passionate nationwide following.
    Its diverse menu features all-American favorites such as Chicago-style hot dogs and sausages, Italian beef sandwiches, chopped salads, burgers, crinkle-cut french fries, homemade chocolate cake and milkshakes.
    Portillo's creates a consumer experience by combining attributes of fast casual and quick service concepts with an exciting energy-filled atmosphere and restaurant model.
    As of June 27, 2021, it owned and operated 67 Portillo’s restaurants across nine states.
    Related:
    IPO-pedia | Hot Dog! Portillo's is going public
    $Dutch Bros(BROS.US)$, based in the Grants Pass in southern Oregon where it was founded in 1992 by brothers Dane and Travis Boersma, is a high-growth operator and franchisor of drive-thru shops.
    According to the filing, Dutch Bros is one of the fastest-growing brands in the foodservice and restaurant industry in the United States by location count. In the past five and a half years, the company has increased shop count from 254 shops in 7 states at the end of 2015 to 471 shops in 11 states as of June 30, 2021.
    As of Oct 21th,it had a market cap of $3.02 billion. It went public on Sep 14h, 2021, with a first-day gain of 59.48% and a listed-to-date gain of 163.39%.
    $Enfusion(ENFN.US)$$P10 Inc(PX.US)$$Ventyx Biosciences(VTYX.US)$$Runway Growth Finance(RWAY.US)$$Vita Coco(COCO.US)$
    IPO Recap | Hot dog chain Portillo's soared 45% in Nasdaq debut
    IPO Recap | Hot dog chain Portillo's soared 45% in Nasdaq debut
    IPO Recap | Hot dog chain Portillo's soared 45% in Nasdaq debut
    +1
Read more

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg